How COVID boosters could be deepening vaccine skepticism


COVID-19 boosters have arrived — and with them, of course, plenty of debate. While health and administration officials reportedly remain at odds over the proper timeline in which to roll out third doses, unvaccinated hold-outs stand steadfast in their relunctance, writes The New York Times, perhaps even hardening in their skepticism thanks to the "mixed messages" from the booster campaign.
"It seems like such a short time and people are already having to get boosters," said Christopher Poe, an unvaccinated manufacturing worker who grew more skeptical about the shot due to the third-dose discourse. "And the fact that they didn't realize that earlier in the rollout shows me that there could be other questions that could be out there, like the long-term effects."
A September vaccine monitor survey from the Kaiser Family Foundation seemed to echo Poe's concerns. There, 71 percent of unvaccinated respondents said they believe the need for boosters means the vaccines aren't working. Officials also fear parents with young children will feel similarly skittish regarding efficacy when the time comes to inoculate their kids.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
The result is "really two different types of campaigns" in the U.S., Dr. Jennifer Avegno, director of the New Orleans health department, told the Times. Physicians are encouring vaccinated the vaccinated to come in for boosters while simulataneously struggling "to defend the need for the third shot to those who have yet to get their first."
Meanwhile, an FDA advisory panel will meet Thursday and Friday to debate booster doses of both the Moderna and Johnson & Johnson vaccines, CNBC reports. Currently, only Pfizer and BioNTech's vaccine has been authorized for use.
As of Saturday, over 7 million Americans had received a booster dose. Read more at The New York Times and CNBC.
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Brigid Kennedy worked at The Week from 2021 to 2023 as a staff writer, junior editor and then story editor, with an interest in U.S. politics, the economy and the music industry.
-
Critics' choice: Outstanding new Japanese restaurants
Feature An all-women sushi team, a 15-seat listening bar, and more
-
Why do Dana White and Donald Trump keep pushing for a White House UFC match?
TODAY'S BIG QUESTION The president and the sports mogul each have their own reasons for wanting a White House spectacle
-
'Quiet vacationing': a secret revolt against workplace culture
The explainer You can be in two places at once
-
RFK Jr. shuts down mRNA vaccine funding at agency
Speed Read The decision canceled or modified 22 projects, primarily for work on vaccines and therapeutics for respiratory viruses
-
Measles cases surge to 33-year high
Speed Read The infection was declared eliminated from the US in 2000 but has seen a resurgence amid vaccine hesitancy
-
Kennedy's vaccine panel signals skepticism, change
Speed Read RFK Jr.'s new vaccine advisory board intends to make changes to the decades-old US immunization system
-
Kennedy ousts entire CDC vaccine advisory panel
speed read Health Secretary RFK Jr. is a longtime anti-vaccine activist who has criticized the panel of experts
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts